0001209191-17-059614.txt : 20171107 0001209191-17-059614.hdr.sgml : 20171107 20171107164334 ACCESSION NUMBER: 0001209191-17-059614 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171103 FILED AS OF DATE: 20171107 DATE AS OF CHANGE: 20171107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wechsler Daniel Mark CENTRAL INDEX KEY: 0001582285 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35405 FILM NUMBER: 171183945 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST CITY: LAVAL STATE: A8 ZIP: H7L 4A8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/ CENTRAL INDEX KEY: 0001461993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262644445 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6320 QUADRANGLE DRIVE STREET 2: SUITE 360 CITY: CHAPEL HILL STATE: NC ZIP: 27517-8149 BUSINESS PHONE: 919-576-2306 MAIL ADDRESS: STREET 1: 6320 QUADRANGLE DRIVE STREET 2: SUITE 360 CITY: CHAPEL HILL STATE: NC ZIP: 27517-8149 FORMER COMPANY: FORMER CONFORMED NAME: CEMPRA, INC. DATE OF NAME CHANGE: 20120203 FORMER COMPANY: FORMER CONFORMED NAME: Cempra Holdings, LLC DATE OF NAME CHANGE: 20090414 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-03 0 0001461993 MELINTA THERAPEUTICS, INC. /NEW/ MLNT 0001582285 Wechsler Daniel Mark C/O MELINTA THERAPEUTICS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511 1 1 0 0 President and CEO Stock Option (Right to Buy) 11.63 2017-11-03 4 A 0 550981 0.00 A 2027-11-03 Common Stock 550981 550981 D Restricted Stock Units 0.00 2017-11-03 4 A 0 183661 0.00 A Common Stock 183661 183661 D The award vests 25% on November 3, 2018 and the remainder will vest in equal monthly installments during the 3 years following the initial vesting date, subject to the Reporting Person's continued employment with the Issuer. /s/ S. Halle Vakani, by Power of Attorney 2017-11-07